These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 36915125)

  • 1. Lipid metabolism-related miRNAs with potential diagnostic roles in prostate cancer.
    Zhai T; Dou M; Ma Y; Wang H; Liu F; Zhang L; Chong T; Wang Z; Xue L
    Lipids Health Dis; 2023 Mar; 22(1):39. PubMed ID: 36915125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential plasma microRNAs signature miR-190b-5p, miR-215-5p and miR-527 as non-invasive biomarkers for prostate cancer.
    Khan MM; Serajuddin M; Bharadwaj M
    Biomarkers; 2023 Mar; 28(2):227-237. PubMed ID: 36644827
    [No Abstract]   [Full Text] [Related]  

  • 4. Identification of Potential miRNAs Biomarkers for High-Grade Prostate Cancer by Integrated Bioinformatics Analysis.
    Foj L; Filella X
    Pathol Oncol Res; 2019 Oct; 25(4):1445-1456. PubMed ID: 30367364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of miRNAs in urine of prostate cancer patients.
    Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
    Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of microRNAs differentially expressed in prostatic secretions of patients with prostate cancer.
    Guzel E; Karatas OF; Semercioz A; Ekici S; Aykan S; Yentur S; Creighton CJ; Ittmann M; Ozen M
    Int J Cancer; 2015 Feb; 136(4):875-9. PubMed ID: 24976077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer.
    Su Z; Wang G; Li L
    Cancer Biomark; 2023; 38(2):143-159. PubMed ID: 37781794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Value of Prostate-Specific Antigen Combined with Plasma miRNA-149 Expression in Patients with Prostate Cancer Based on Experimental Data and Bioinformatics.
    Wang H; Yang L; Mi Y; Wang Y; Ma C; Zhao J; Liu P; Gao Y; Li P
    Contrast Media Mol Imaging; 2022; 2022():6094409. PubMed ID: 35935308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel six autophagy-related genes signature for the prognostic and a miRNA-related autophagy predictor for anti-PD-1 therapy responses in prostate cancer.
    Wu L; Quan W; Yue G; Luo Q; Peng D; Pan Y; Zhang G
    BMC Cancer; 2021 Jan; 21(1):15. PubMed ID: 33402116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of aberrant miRNA-mRNA interaction networks in prostate cancer to conjecture its molecular mechanisms.
    Peng S; Liu C; Fan X; Zhu J; Zhang S; Zhou X; Wang T; Gao F; Zhu W
    Cancer Biomark; 2022; 35(4):395-407. PubMed ID: 36373308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics, clinical significance, and cancer immune interactions of lipid metabolism in prostate cancer.
    Xu Z; Xu X; Hu J; Tan J; Wan Y; Cui F
    Transl Cancer Res; 2024 Jul; 13(7):3575-3588. PubMed ID: 39145061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of an individualized metabolic prognostic signature for predicting the biochemical recurrence of prostate cancer based on the immune microenvironment.
    Hu B; Zhang X; Zhu S; Wang C; Deng Z; Wang T; Wu Y
    Eur J Med Res; 2024 Jan; 29(1):92. PubMed ID: 38297388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of miRNA-mRNA-TF Regulatory Network for Diagnosis of Gastric Cancer.
    Fu Z; Xu Y; Chen Y; Lv H; Chen G; Chen Y
    Biomed Res Int; 2021; 2021():9121478. PubMed ID: 34840985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of miRNA host gene promoter methylation in prostate cancer.
    Daniunaite K; Dubikaityte M; Gibas P; Bakavicius A; Rimantas Lazutka J; Ulys A; Jankevicius F; Jarmalaite S
    Hum Mol Genet; 2017 Jul; 26(13):2451-2461. PubMed ID: 28398479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening the key microRNAs and transcription factors in prostate cancer based on microRNA functional synergistic relationships.
    Feng F; Wu J; Gao Z; Yu S; Cui Y
    Medicine (Baltimore); 2017 Jan; 96(1):e5679. PubMed ID: 28072703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 in peripheral blood mononuclear cells as a novel biomarker in the diagnosis and prognosis of prostate cancer.
    Yang B; Liu Z; Ning H; Zhang K; Pan D; Ding K; Huang W; Kang XL; Wang Y; Chen X
    Cancer Biomark; 2016 Jul; 17(2):223-30. PubMed ID: 27434290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profile analysis of microRNAs in prostate cancer by next-generation sequencing.
    Song C; Chen H; Wang T; Zhang W; Ru G; Lang J
    Prostate; 2015 Apr; 75(5):500-16. PubMed ID: 25597612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of a transcription factor-miRNA-mRNA interactive network elucidates underlying pathogenesis for osteosarcoma and validation by qRT-PCR.
    Tang F; Jiang X; Liao S; Liu Y; He M
    Medicine (Baltimore); 2022 Oct; 101(41):e31049. PubMed ID: 36254052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network.
    Tang Z; Wei G; Zhang L; Xu Z
    Mol Med Rep; 2019 Jun; 19(6):4806-4818. PubMed ID: 31059106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
    Jin W; Fei X; Wang X; Chen F; Song Y
    J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.